Year: 2021

Florida-based Association contracts to make FOREWARN services available for its 2,200+ REALTOR® members to promote proactive agent safety BOCA RATON, Fla., Dec. 22, 2021 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Daytona Beach Area Association of REALTORS® (“DBAAR”) has contracted to make FOREWARN® services available for the 2,200+ REALTOR® members it serves throughout the Daytona Beach area to promote proactive real estate agent safety. Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information provided by potential clients...

DENVER, Dec. 22, 2021 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors, announced that Maureen Hewitt, Chief Executive Officer, will be presenting virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 8:15 p.m. (ET). The presentation will include a virtual fireside chat and Patrick Blair, President, and Barb Gutierrez, Chief Financial Officer, will also be participating. The appearance will be webcast live, and the webcast link and related presentation materials for the event will be available online at https://investor.innovage.com/investor-relations. About InnovAgeInnovAge is a market leader in managing the care of high-cost, dual-eligible seniors. Our mission is to...

BOSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in the H.C. Wainwright Virtual BioConnect 2022 Conference, which is taking place from Monday, January 10th to Thursday, January 13th. A webcast of the fireside chat with AVEO’s management team and H.C. Wainwright research analyst Swayampakula Ramakanth will be available on-demand as of 7 a.m. EST on Monday, January 10th, by visiting the Calendar of Events sub-section within the Investors section of the Company’s website at www.aveooncology.com. About AVEO Pharmaceuticals, Inc AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with...

SOUTH SAN FRANCISCO, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that from December 7, 2021, through December 21, 2021, the Compensation Committee of the Board of Directors (the “Board”) granted a new employee a stock-based award covering an aggregate of 4,500 shares of UNITY common stock, including options to purchase an aggregate of 4,500 shares of UNITY common stock. The stock-based award was granted pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as amended, which was approved by the Board in March 2020 to provide for grants to newly hired employees as a material inducement for them to commence employment with UNITY in accordance with Nasdaq Stock Market...

VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) — Kutcho Copper Corp. (TSXV: KC, OTCQX: KCCFF) (“Kutcho Copper” or the “Company”) is pleased to announce, as described in the press release dated July 6th, 2021, it has completed the buy back of the royalty held by Sumac Mines (now Sumitomo Metal Mining Canada) (the “Sumac Royalty”) and has terminated Sumac’s Right of First Refusal to purchase concentrates (the “Sumac ROFR”) from the Kutcho copper-zinc project, both of which rights were granted under an Acquisition Agreement between Sumac Mines Ltd. and Western Keltic Mines Inc. dated August 29, 2003. Kutcho Copper President and CEO, Vince Sorace, commented: “We view the completion of this transaction as a highly accretive to the Company. The termination of the Sumac ROFR gives the Company full flexibility to engage freely...

Investview Continues Strong Monthly Results Across Business Divisions: November 2021 Gross Revenue Growth of 247% year-over-year to $10.2 million and Operating Income Growth of 426% year-over-year to $3.4 million.Gross Revenue of $10.2 million, up 247% Year-Over-Year November Income from Operations of $3.4 million, up 426% Year-Over-Year November Net Revenue of $9.5 million, up 230% Year-Over-Year November Net Income of $3.6 million (includes non-operating income), down $0.2 million or -4% Year-Over-Year November iGenius Subscription and NDAU Gross Revenue of $8.1 million, up 437% Year-Over-Year November iGenius Membership Subscription Record Gross Revenue of $7.6 million, up 407% Year-Over-Year November SAFETek Bitcoin Mining Gross Revenue of $2.1 million, up 46% Year-Over-Year November Bitcoin Mined over 19 months period ending November...

BURLINGTON, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) — Avid® (NASDAQ: AVID), a leading technology provider that powers the media and entertainment industry, today announced that its executive management will participate in an investor conference during January 2022. 24th Annual Needham Virtual Growth Conference Participants: Jeff Rosica, Chief Executive Officer and President           Ken Gayron, Chief Financial Officer and EVPType: Group Presentation and 1×1 MeetingsDate: Wednesday, January 12, 2022 Group Presentation Time: 8:30AM ETThe Group Presentation will be available to the public via live webcast, and a replay will be available for a limited period. For details on how to listen online, please visit the Events & Presentations page on http://ir.avid.com. About AvidAvid delivers the most open and efficient media platform,...

Antiviral activity now confirmed against SARS-CoV-2 and all variants of concernincluding Omicron, Delta, Alpha, Beta and Gamma  BOTHELL, Wash., Dec. 22, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that in vitro studies demonstrate its oral and intranasal/pulmonary SARS-CoV-2 main protease inhibitors exhibit antiviral potency against the Omicron variant. The Company earlier confirmed that its protease inhibitors demonstrated broad-spectrum antiviral activity against SARS-CoV-2 and all major previously identified variants including Delta, Alpha, Beta and Gamma. Cocrystal expects to initiate Phase 1 clinical studies with its COVID-19 intranasal/pulmonary protease inhibitor CDI-45205 and an oral COVID-19 protease inhibitor as rapidly as possible. To confirm the antiviral activity...

DANBURY, Conn., Dec. 22, 2021 (GLOBE NEWSWIRE) — FuelCell Energy (Nasdaq: FCEL), a global leader in fuel cell technology with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy— today announced the upcoming release of its fourth quarter and fiscal year 2021 results prior to the Stock Market Open on Wednesday, December 29, 2021. FuelCell Energy is now classified by the Securities and Exchange Commission as a large accelerated filer, and as such the Company is required to file its annual report on form 10-K with the SEC no later than 60 days following the Company’s fiscal year end of October 31st. FuelCell Energy management will host a conference call with investors beginning at 8:00 a.m. Eastern Time on Wednesday, December 29, 2021 to discuss the fourth quarter...

In addition, Mercedes-Benz first automaker to deploy Cerence Emergency Vehicle Detection BURLINGTON, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that Mercedes-Benz AG has selected Cerence to provide enhanced capabilities, including conversational AI-powered electric vehicle use cases and Cerence Emergency Vehicle Detection (EVD), within its intuitive multimedia system, MBUX – Mercedes-Benz User Experience – in the new Mercedes-Benz EQS, the first all-electric luxury sedan from the Mercedes-EQ lineup. Building on the companies’ partnership on the next-gen MBUX introduced last year, MBUX in the Mercedes-Benz EQS features a new set of electric vehicle-related capabilities and use cases powered by Cerence that simplify the EV ownership experience for Mercedes-Benz EQS...